1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
Multiple System Atrophy
Ruijin HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
16 Active assets in the Multiple System Atrophy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Droxidopa Loma Linda University | Phase 3 | BB |
Zoledronate California Pacific Medical Center Research Institute | Phase 4 | BB |
INCOBOTULINUMTOXINA University Of Perugia | Phase 4 | BB |
ATH-434 Alterity Therapeutics | Phase 2 | B |
Riluzole King's College London | Phase 3 | B |
View all 27 →
Same molecule, other indications
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →